Inhibition of microglia activation as a phenotypic assay in early drug discovery.

Abstract excerpt

Complex biological processes such as inflammation, cell death, migration, proliferation, and the release of biologically active molecules can be used as outcomes in phenotypic assays during early stages of drug discovery. Although target-based approaches have been widely used over the past decades, a disproportionate number of first-in-class drugs have been identified using phenotypic screening. This review...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Discovery
• Share to Drug Evaluation, Preclinical
• Share to Microglia